Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acorda Therapeutics (NQ: ACOR )

0.6000 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 60
Open 0.6000
Bid (Size) 0.5700 (2)
Ask (Size) 0.6000 (7)
Prev. Close 0.6000
Today's Range 0.6000 - 0.6000
52wk Range 0.2611 - 1.740
Shares Outstanding 24,337,696
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Acorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual Company Presentation and Q&A
From Acorda Therapeutics
Via Business Wire
Acorda Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
From Acorda Therapeutics
Via Business Wire

Performance

YTD
-23.57%
-23.57%
1 Month
-35.14%
-35.14%
3 Month
-4.00%
-4.00%
6 Month
+106.11%
+106.11%
1 Year
-64.07%
-64.07%

More News

Read More
ESTEVE Launches INBRIJA® in Spain
From Acorda Therapeutics
Via Business Wire
Acorda Fourth Quarter/Year End 2022 Update: Webcast/Conference Call Scheduled for March 9, 2023
From Acorda Therapeutics
Via Business Wire
Acorda Therapeutics Receives Nasdaq Extension to Meet Minimum Bid Price Requirement
From Acorda Therapeutics
Via Business Wire
Acorda Therapeutics to Present at Sequire Biotechnology Conference
From Acorda Therapeutics
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Acorda Therapeutics Announces New Agreement with Catalent for Long-Term Global Supply of INBRIJA®
From Acorda Therapeutics
Via Business Wire
Acorda Therapeutics Announces Revised Long-Term Financial Guidance
From Acorda Therapeutics
Via Business Wire
Acorda Therapeutics Receives Nasdaq Listing Determination Letter and Plans to Request a Hearing
From Acorda Therapeutics
Via Business Wire
Acorda Therapeutics Makes December 2022 $6.2 Million Interest Payment on Secured Debt in Cash
From Acorda Therapeutics
Via Business Wire
Acorda Therapeutics Announces Passage of Reverse Stock Split Proposal at its Special Meeting of Stockholders
From Acorda Therapeutics
Via Business Wire
How Is The Market Feeling About Acorda Therapeutics?
Via Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Acorda Therapeutics Announces Adjournment of Special Meeting of Stockholders
From Acorda Therapeutics
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Acorda Therapeutics Reports Third Quarter 2022 Financial Results
From Acorda Therapeutics
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Via Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Goodyear Tire & Rubber Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
Via Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.